ReBio Technologies
Cranleigh
About ReBio Technologies
ReBio Technologies is an industrial biotechnology company that specializes in the developing proprietary routes to key commodity platform biochemicals from renewable resources. It also develops tools in biotechnology to elucidate and design new biosynthetic pathways in a range of microbial hosts, for the efficient and cost-effective production of high-value chemicals through fermentation. This, coupled with state-of-the-art polymer technology, provides manufacturing industries with innovative solutions to their raw material requirements. It was founded in 2014 and is headquartered in Cranleigh, Surrey, United Kingdom.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $5.5M
- Funding stage: Seed
- Last round: Grant (Jan 2020)
- Website: rebiopharma.com
- Phone: +44 (0)1483 330230
Industries & Categories
Biotechnology, Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/rebio-technologies-35369 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.